ATE397085T1 - Verfahren zur reproduzierung von pleuromutilinen - Google Patents

Verfahren zur reproduzierung von pleuromutilinen

Info

Publication number
ATE397085T1
ATE397085T1 AT03784267T AT03784267T ATE397085T1 AT E397085 T1 ATE397085 T1 AT E397085T1 AT 03784267 T AT03784267 T AT 03784267T AT 03784267 T AT03784267 T AT 03784267T AT E397085 T1 ATE397085 T1 AT E397085T1
Authority
AT
Austria
Prior art keywords
pleuromutilines
reproducing
mammal
invented
human
Prior art date
Application number
AT03784267T
Other languages
English (en)
Inventor
Michael John Rees
Keith Graham Robins
Anna Louisa Stefanska
Jan Edward Thirkettle
Michael Sidney Verrall
David Alan Yeandle
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE397085T1 publication Critical patent/ATE397085T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P15/00—Preparation of compounds containing at least three condensed carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pulleys (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT03784267T 2002-08-09 2003-08-07 Verfahren zur reproduzierung von pleuromutilinen ATE397085T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0218578.3A GB0218578D0 (en) 2002-08-09 2002-08-09 Novel method

Publications (1)

Publication Number Publication Date
ATE397085T1 true ATE397085T1 (de) 2008-06-15

Family

ID=9942054

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03784267T ATE397085T1 (de) 2002-08-09 2003-08-07 Verfahren zur reproduzierung von pleuromutilinen

Country Status (13)

Country Link
US (1) US7556948B2 (de)
EP (1) EP1537226B1 (de)
JP (1) JP4381303B2 (de)
AT (1) ATE397085T1 (de)
AU (1) AU2003249090A1 (de)
CY (1) CY1108221T1 (de)
DE (1) DE60321355D1 (de)
DK (1) DK1537226T3 (de)
ES (1) ES2305545T3 (de)
GB (1) GB0218578D0 (de)
PT (1) PT1537226E (de)
SI (1) SI1537226T1 (de)
WO (1) WO2004015122A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1686115A1 (de) * 2005-01-26 2006-08-02 Novartis AG Organische Säureadditionssalze von Valnemulin
CN101676257A (zh) * 2008-09-17 2010-03-24 大英九合生物化工股份有限公司 一种高纯度截短侧耳素原料的发酵提取制备方法
EP2494028A4 (de) * 2009-10-30 2015-04-01 Glaxo Group Ltd Verfahren zur erhöhung des ertrags von pleuromutilinen
EP2366782A1 (de) * 2010-03-09 2011-09-21 Sandoz AG Polypeptid mit Diterpensynthase-Aktivität
CN101885681B (zh) * 2010-06-29 2013-06-12 金河生物科技股份有限公司 截短侧耳素的超临界二氧化碳萃取工艺
CN102351698A (zh) * 2011-08-15 2012-02-15 上海华震科技有限公司 一种用吸附色谱法从结晶母液中回收截短侧耳素的方法
TWI762573B (zh) * 2017-02-10 2022-05-01 奧地利商納畢瓦治療有限責任公司 截短側耳素之純化
CN111979276A (zh) * 2020-08-28 2020-11-24 山东胜利生物工程有限公司 一种截短侧耳素发酵方法与系统
CN112919463B (zh) * 2021-04-09 2021-10-26 南京理工大学 一种利用泰妙菌素废盐制备的活性炭及其制备方法

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4092424A (en) 1964-04-17 1978-05-30 Biochemie Ges.M.B.H. Antibiotic derivatives
US3949079A (en) 1964-04-17 1976-04-06 Biochemie Ges.M.B.H. Antibiotic derivatives
GB1197942A (en) 1967-08-15 1970-07-08 Biochemie Gmbh Process for the production of the Antibiotic Pleuromutilin
GB1200159A (en) 1967-08-15 1970-07-29 Biochemie Gmbh Veterinary antibiotic compositions
AT301752B (de) 1969-07-21 1972-09-25 Biochemie Gmbh Verfahren zur Herstellung neuer Pleuromutilin-Derivate
CH572894A5 (en) 1972-07-07 1976-02-27 Sandoz Ag Pleuromutilin aminoalkoxy(thio)-substd. esters prepn. - by reacting hydroxy-or mercapto-substd. esters with e.g. aminoalkyl halides
CH612995A5 (de) 1975-07-23 1979-08-31 Biochemie Gmbh
CH619450A5 (de) * 1976-01-15 1980-09-30 Sandoz Ag
US4130709A (en) 1977-12-08 1978-12-19 Eli Lilly And Company Pleuromutilin glycoside derivatives
US4129721A (en) 1977-12-08 1978-12-12 Eli Lilly And Company A-40104 antibiotics and process for production thereof
BE864361A (fr) 1978-02-27 1978-08-28 Biochemie Gmbh Solvats de la pleuromutiline et procede de purification de la pleuromutiline par l'intermediaire de tels solvats
DE2809046A1 (de) 1978-03-02 1979-09-13 Biochemie Gmbh In einem halogenierten kohlenwasserstoff solvatisiertes pleuromutilin und verfahren zu seiner herstellung
GB2025930B (en) 1978-06-01 1983-02-09 Sandoz Ltd Process for the production of pleuromutilin derivatives
US4247542A (en) 1978-06-22 1981-01-27 Eli Lilly And Company A-40104 Antibiotics and process for production thereof
US4308375A (en) 1980-10-06 1981-12-29 E. R. Squibb & Sons, Inc. Method for purifying water-insoluble polyene antibiotics
HU183266B (en) 1980-12-15 1984-04-28 Richter Gedeon Vegyeszet Process for the extraction of non-filtered fermentation liquors produced by strains of claviceps purpurea
FR2526019A1 (fr) 1982-04-28 1983-11-04 Sandoz Sa Nouveaux derives de la pleuromutiline, leur preparation et leur utilisation comme medicaments
DE3318194C2 (de) 1983-05-19 1987-01-22 Fried. Krupp Gmbh, 4300 Essen Verfahren zur Isolierung und Reinigung von Antibiotika
DE3617803A1 (de) 1985-11-07 1987-11-19 Bayer Ag Verwendung von gyrasehemmern zur dekontamination von mycoplasma-infizierten zellkulturen
AT400674B (de) 1991-07-24 1996-02-26 Biochemie Gmbh Pharmazeutische pleuromutilin-zubereitung
AT397654B (de) 1992-05-04 1994-06-27 Biochemie Gmbh Neue pleuromutilinderivate, ihre verwendung und verfahren zu ihrer herstellung
ES2188602T3 (es) 1994-10-20 2003-07-01 Chevita Tierarzneimittel Gmbh Procedimiento para la produccion de piensos que contienen substancias farmacologicamente activas.
IL124912A0 (en) 1996-01-03 1999-01-26 Smithkline Beecham Plc Carbamoyloxy derivatives of mutiline and their use as antibacterials
HUP0001741A3 (en) 1996-08-02 2000-11-28 Smithkline Beecham Plc Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use, process for preparing them, pharmaceuticals contg. them and their use
UY25225A1 (es) 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
WO2000027790A1 (en) 1998-11-11 2000-05-18 Smithkline Beecham P.L.C. Mutilin compounds
WO2000037074A1 (en) 1998-12-18 2000-06-29 Smithkline Beecham Plc Mutilin 14-ester derivatives having antibacterial activity
GB9912657D0 (en) 1999-06-01 1999-07-28 Smithkline Beecham Plc Novel compounds
GB9919839D0 (en) 1999-08-20 1999-10-27 Smithkline Beecham Plc Novel compounds
BR0109809A (pt) 2000-04-04 2003-01-21 Smithkline Beecham Plc Derivados do carbamato de 2-hidroxi-mutilina para uso antibacteriano
GB0018951D0 (en) 2000-08-03 2000-09-20 Smithkline Beecham Plc Novel compounds
GB0024811D0 (en) 2000-10-10 2000-11-22 Smithkline Beecham Plc Novel compounds
GB0027705D0 (en) 2000-11-11 2000-12-27 S P A Novel compounds

Also Published As

Publication number Publication date
DK1537226T3 (da) 2008-09-15
SI1537226T1 (sl) 2008-10-31
AU2003249090A1 (en) 2004-02-25
WO2004015122A1 (en) 2004-02-19
EP1537226A1 (de) 2005-06-08
US20060166341A1 (en) 2006-07-27
DE60321355D1 (de) 2008-07-10
JP2005535324A (ja) 2005-11-24
PT1537226E (pt) 2008-07-30
US7556948B2 (en) 2009-07-07
ES2305545T3 (es) 2008-11-01
CY1108221T1 (el) 2014-02-12
JP4381303B2 (ja) 2009-12-09
EP1537226B1 (de) 2008-05-28
GB0218578D0 (en) 2002-09-18

Similar Documents

Publication Publication Date Title
ATE350044T1 (de) Thrombopoietinmimetika
DE60025632D1 (de) Thrombopoietin-mimetika
CY1108221T1 (el) Μεθοδος για την αναπαραγωγη πλευρομουτιλινων
ATE344031T1 (de) Thrombopoietin-mimetika
DE602004014117D1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
ME00185B (me) Specifični agensi koji vezuju humani angiopoetin-2
DE60327999D1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
DE60319364D1 (de) Substituierte pyrroline als kinase inhibitoren
ATE420947T1 (de) Gewebeimplant zur wiederherstellung von knorpelgewebe
DE60328150D1 (de) System und Methode zur Erzeugung von Anfangs-Vektoren
ATE435012T1 (de) Verfahren zur behandlung von parkinson-krankheit
DE60328492D1 (de) Verfahren zur erzeugung von nanoteilchen
DE60237184D1 (de) Verfahren zur Erzeugung von Bewegungen
ATE513550T1 (de) Verwendung eines ibat-hemmers zur behandlung oder vorbeugung von verstopfung
ATE315390T1 (de) Zyklische polyamine zur behandlung der thrombozytopenie
ATE521357T1 (de) Verfahren zur behandlung von hepatitis
DE60334517D1 (de) System und Verfahren zur Durchführung von am-Chip Selbsttests
DE602004012578D1 (de) Als inhibitoren von c-met geeignete pyrrolzusammensetzungen
ATE515268T1 (de) Verwendung von op-1 zur behandlung von knorpeldefekten
DE502004004773D1 (de) Verfahren zur ansteuerung von personenschutzmitteln
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
ATE473729T1 (de) Verfahren zur behandlung von rosacea und telangiectasia
DE60103503D1 (de) Verwendung von fsh zur behandlung von infertilität
ATE251462T1 (de) Verfahren zur behandlung von narbengewebe
ATE522601T1 (de) Varianten von antithrombin iii

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1537226

Country of ref document: EP